Meningococcal disease, infants

Due to a lack of safety data, MCV4 is not recommended in pregnancy. A review of VAERS reports in pregnant women who received MenACWY-D inadvertently between January 2005 and December 2011 did not identify any concerning patterns in maternal, foetal or infant outcomes. The authors comment that their review, while limited, supports the current ACIP recommendations that pregnancy should not preclude MenACWY-D vaccination in women at increased risk for meningococcal disease (e.g. in a disease outbreak) [91 J. 

---